Time to review the role of surrogate endpoints in health policy: state of the art and the way forward

Ciani, O., Buyse, M., Drummond, M.F. orcid.org/0000-0002-6126-0944 et al. (3 more authors) (2017) Time to review the role of surrogate endpoints in health policy: state of the art and the way forward. Value in Health. pp. 487-495. ISSN 1524-4733

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2016 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details.
Keywords: clinical outcome assessment, surrogate endpoints, validation, health technology assessment
Dates:
  • Published (online): 22 December 2016
  • Published: 6 March 2017
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York)
Depositing User: Pure (York)
Date Deposited: 04 Jan 2017 14:16
Last Modified: 02 Sep 2019 23:49
Published Version: https://doi.org/10.1016/j.jval.2016.10.011
Status: Published
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jval.2016.10.011

Download

Filename: OC_MB_MD_etc_rev_role_Surrogates_ViH_acceptd_201016.pdf

Description: OC MB MD etc rev role Surrogates ViH acceptd 201016

Licence: CC-BY-NC-ND 2.5

Share / Export

Statistics